Health

Results: 361-372 of 10101

PR Newswire associated0

JEGI LEONIS Has Advised Forge, a Portfolio Company of Apollo, on Their Definitive Agreement to Acquire Becker's Healthcare, a Portfolio Company of Pamlico Capital

First patient treated with Leqembi® (lecanemab) in Sweden

PR Newswire associated0

Altruist Biologics' Suzhou Site Receives EMA GMP Certification, Enabling Product Commercialization for the European Market

Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 2026

SK pharmteco and GEMMABio Expand Rare Disease Manufacturing Collaboration Following Important Spinal Muscular Atrophy (SMA) Clinical Trial Milestone

From CSR to Public Health Impact: How Colgate Bright Smiles, Bright Futures® is Driving Behavior Change for the Next Billion Children and Their Families

New Research Provides Groundbreaking Look Into Brain Processes Behind PANS, PANDAS, Sydenham’s Chorea

Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio

PR Newswire associated0

Claros Technologies Announces Continued Commercial Expansion into Europe and Entry into Pharmaceutical Manufacturing with a Successful PFAS Destruction Pilot at Bachem AG

Vertex Announces Positive Results From Phase 2b AMPLIFIED Study of Inaxaplin in Additional Populations of People With APOL1-Mediated Kidney Disease (AMKD) and Completion of Enrollment in the Phase 2/3 AMPLITUDE Trial

PR Newswire associated0

Biocon's Pertuzumab Becomes First Biosimilar to Secure EMA CHMP Approval Recommendation Under New Tailored Clinical Approach

Glasgow author James McInally

“I’m Drinking More Than I Want To”: Hazardous Drinking Among Women Aged 55–64 Has Risen Nearly 80% Since 2000